The long-term clinical implications of clonal chromosomal abnormalities in newly diagnosed chronic phase chronic myeloid leukemia patients treated with imatinib mesylate. [electronic resource]
Producer: 20130404Description: 563-71 p. digitalISSN:- 2210-7762
- Adult
- Aged
- Antineoplastic Agents -- therapeutic use
- Benzamides
- Chromosome Aberrations
- Female
- Humans
- Imatinib Mesylate
- Leukemia, Myeloid, Chronic-Phase -- drug therapy
- Male
- Middle Aged
- Multivariate Analysis
- Piperazines -- therapeutic use
- Prognosis
- Pyrimidines -- therapeutic use
- Regression Analysis
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.